Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 15/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 13/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 5/20 | 0.49 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.43 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | HTR3A | P46098 | 1/20 | 0.39 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22491409 | 0.82 | SETD7 (0.50) | OPRD1OPRM1OPRK1SETD7KCNH2 | |
| SCHEMBL2457390 | 0.77 | OPRD1 (0.61) | OPRD1OPRM1OPRK1SETD7KCNH2 | |
| Bromide SCHEMBL10598951 | 0.75 | OPRD1 (0.59) | OPRD1OPRM1OPRK1SETD7KCNH2 | |
| Hydrochloric Acid SCHEMBL7647391 | 0.75 | OPRD1 (0.59) | OPRD1OPRM1OPRK1SETD7KCNH2 | |
| SCHEMBL8316576 | 0.71 | OPRD1 (0.60) | OPRD1OPRM1OPRK1SETD7KCNH2 | |
| SCHEMBL22491524 | 0.71 | OPRM1 (0.50) | OPRD1OPRM1OPRK1KCNH2ABCB11 | |
| SCHEMBL15569569 | 0.71 | OPRD1 (0.47) | OPRD1OPRM1OPRK1SETD7KCNH2 | |
| SCHEMBL8313290 | 0.71 | OPRM1 (0.49) | OPRD1OPRM1OPRK1SETD7KCNH2 | |
| SCHEMBL22773372 | 0.70 | OPRD1 (0.49) | OPRD1OPRM1OPRK1SETD7KCNH2 | |
| SCHEMBL9434960 | 0.70 | OPRD1 (0.57) | OPRD1OPRM1OPRK1SETD7KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11420961-B2 | Heterocyclic compounds | HOFFMANN-LA ROCHE INC. (US) | 2022-08-23 | — | — | US | disclosed |
| EP-3717477-B1 | NEW HETEROCYCLIC COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2022-07-20 | — | — | EP | disclosed |
| US-20200392125-A1 | HETEROCYCLIC COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 2020-12-17 | — | — | US | disclosed |
| EP-3717477-A1 | NEW HETEROCYCLIC COMPOUNDS | H. Hoffnabb-La Roche Ag (CH) | 2020-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11420961-B2 | Heterocyclic compounds | LPXN, MLX, CCNY | OPRD1 1395/4885OPRM1 549/4885OPRK1 1592/4885 |
| US-20200392125-A1 | HETEROCYCLIC COMPOUNDS | LPXN, MLX, CCNY | OPRD1 1395/4885OPRM1 549/4885OPRK1 1592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.